DNA Methylation Profiles Distinguish Different Subtypes of Gastroenteropancreatic Neuroendocrine Tumors

References

• Kloppel G , AnlaufM . Epidemiology, tumour biology and histopathological classification of neuroendocrine tumours of the gastrointestinal tract . Best Pract. Res. Clin. Gastroenterol.19 ( 4 ), 507 – 517 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Fraenkel M , KimMK , FaggianoA , ValkGD . Epidemiology of gastroenteropancreatic neuroendocrine tumours . Best Pract. Res. Clin. Gastroenterol.26 ( 6 ), 691 – 703 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Kanakis G , KaltsasG . Biochemical markers for gastroenteropancreatic neuroendocrine tumours (GEP-NETs) . Best Pract. Res. Clin. Gastroenterol.26 ( 6 ), 791 – 802 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Meeker A , HeaphyC . Gastroenteropancreatic endocrine tumors . Mol. Cell. Endocrinol.386 ( 1–2 ), 101 – 120 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Strosberg J . Neuroendocrine tumours of the small intestine . Best Pract. Res. Clin. Gastroenterol.26 ( 6 ), 755 – 773 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Ito T , IgarashiH , JensenRT . Pancreatic neuroendocrine tumors: clinical features, diagnosis and medical treatment: advances . Best Pract. Res. Clin. Gastroenterol.26 ( 6 ), 737 – 753 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Zikusoka MN , KiddM , EickG , LatichI , ModlinIM . The molecular genetics of gastroenteropancreatic neuroendocrine tumors . Cancer104 ( 11 ), 2292 – 2309 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Mapelli P , AboagyeEO , StebbingJ , SharmaR . Epigenetic changes in gastroenteropancreatic neuroendocrine tumours . Oncogene34 ( 34 ), 4439 – 4447 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Karpathakis A , DibraH , ThirlwellC . Neuroendocrine tumours: cracking the epigenetic code . Endocr. Relat. Cancer20 ( 3 ), R65 – R82 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Duerr EM , MizukamiY , NgAet al. Defining molecular classifications and targets in gastroenteropancreatic neuroendocrine tumors through DNA microarray analysis . Endocr. Relat. Cancer15 ( 1 ), 243 – 256 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Muscarella P , MelvinWS , FisherWEet al. Genetic alterations in gastrinomas and nonfunctioning pancreatic neuroendocrine tumors: an analysis of p16/MTS1 tumor suppressor gene inactivation . Cancer Res.58 ( 2 ), 237 – 240 ( 1998 ).
   PubMed Web of Science ®Google Scholar
• Chung DC , BrownSB , Graeme-CookFet al. Overexpression of cyclin D1 occurs frequently in human pancreatic endocrine tumors . J. Clin. Endocrinol. Metab.85 ( 11 ), 4373 – 4378 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Guo SS , WuX , ShimoideAT , WongJ , SawickiMP . Anomalous overexpression of p27(Kip1) in sporadic pancreatic endocrine tumors . J. Surg. Res.96 ( 2 ), 284 – 288 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Goebel SU , IwamotoM , RaffeldMet al. Her-2/neu expression and gene amplification in gastrinomas: correlations with tumor biology, growth, and aggressiveness . Cancer Res.62 ( 13 ), 3702 – 3710 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Fjallskog ML , LejonklouMH , ObergKE , ErikssonBK , JansonET . Expression of molecular targets for tyrosine kinase receptor antagonists in malignant endocrine pancreatic tumors . Clin. Cancer Res.9 ( 4 ), 1469 – 1473 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• House MG , HermanJG , GuoMZet al. Prognostic value of hMLH1 methylation and microsatellite instability in pancreatic endocrine neoplasms . Surgery134 ( 6 ), 902 – 908 ; discussion 909 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• House MG , HermanJG , GuoMZet al. Aberrant hypermethylation of tumor suppressor genes in pancreatic endocrine neoplasms . Ann. Surg.238 ( 3 ), 423 – 431 ; discussion 431–422 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Missiaglia E , DalaiI , BarbiSet al. Pancreatic endocrine tumors: expression profiling evidences a role for AKT-mTOR pathway . J. Clin. Oncol.28 ( 2 ), 245 – 255 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Jiao Y , ShiC , EdilBHet al. DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors . Science331 ( 6021 ), 1199 – 1203 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Briest F , GrabowskiP . PI3K–AKT–mTOR-signaling and beyond: the complex network in gastroenteropancreatic neuroendocrine neoplasms . Theranostics4 ( 4 ), 336 – 365 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Francis JM , KiezunA , RamosAHet al. Somatic mutation of CDKN1B in small intestine neuroendocrine tumors . Nat. Genet.45 ( 12 ), 1483 – 1486 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Capurso G , FestaS , ValenteRet al. Molecular pathology and genetics of pancreatic endocrine tumours . J. Mol. Endocrinol.49 ( 1 ), R37 – R50 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Karpathakis A , DibraH , PipinikasCet al. Prognostic impact of novel molecular subtypes of small intestinal neuroendocrine tumour . Clin. Cancer. Res. doi:10.1158/1078-0432 ( 2015 ) ( Epub ahead of print ).
   PubMed Web of Science ®Google Scholar
• Dawson MA , KouzaridesT . Cancer epigenetics: from mechanism to therapy . Cell150 ( 1 ), 12 – 27 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Baylin SB , JonesPA . A decade of exploring the cancer epigenome – biological and translational implications . Nat. Rev. Cancer11 ( 10 ), 726 – 734 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• How Kit A , NielsenHM , TostJ . DNA methylation based biomarkers: practical considerations and applications . Biochimie94 ( 11 ), 2314 – 2337 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Chan AO , KimSG , BedeirA , IssaJP , HamiltonSR , RashidA . CpG island methylation in carcinoid and pancreatic endocrine tumors . Oncogene22 ( 6 ), 924 – 934 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Choi IS , EstecioMR , NaganoYet al. Hypomethylation of LINE-1 and Alu in well-differentiated neuroendocrine tumors (pancreatic endocrine tumors and carcinoid tumors) . Mod. Pathol.20 ( 7 ), 802 – 810 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Serrano J , GoebelSU , PeghiniPL , LubenskyIA , GibrilF , JensenRT . Alterations in the p16INK4a/CDKN2A tumor suppressor gene in gastrinomas . J. Clin. Endocrinol. Metab.85 ( 11 ), 4146 – 4156 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Liu L , BroaddusRR , YaoJCet al. Epigenetic alterations in neuroendocrine tumors: methylation of RAS-association domain family 1, isoform A and p16 genes are associated with metastasis . Mod. Pathol.18 ( 12 ), 1632 – 1640 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Malpeli G , AmatoE , DandreaMet al. Methylation-associated down-regulation of RASSF1A and up-regulation of RASSF1C in pancreatic endocrine tumors . BMC Cancer11 , 351 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Stefanoli M , La RosaS , SahnaneNet al. Prognostic relevance of aberrant DNA methylation in g1 and g2 pancreatic neuroendocrine tumors . Neuroendocrinology100 ( 1 ), 26 – 34 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Ohki R , SaitoK , ChenYet al. PHLDA3 is a novel tumor suppressor of pancreatic neuroendocrine tumors . Proc. Natl Acad. Sci. USA111 ( 23 ), e2404 – e2413 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Yokoyama A , SomervailleTC , SmithKS , Rozenblatt-RosenO , MeyersonM , ClearyML . The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis . Cell123 ( 2 ), 207 – 218 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Grembecka J , BelcherAM , HartleyT , CierpickiT . Molecular basis of the mixed lineage leukemia-menin interaction: implications for targeting mixed lineage leukemias . J. Biol. Chem.285 ( 52 ), 40690 – 40698 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Lin W , WatanabeH , PengSet al. Dynamic epigenetic regulation by menin during pancreatic islet tumor formation . Mol. Cancer Res.13 ( 4 ), 689 – 698 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Pipinikas CP , DibraH , KarpathakisAet al. Epigenetic dysregulation and poorer prognosis in DAXX-deficient pancreatic neuroendocrine tumours . Endocr. Relat. Cancer22 ( 3 ), L13 – L18 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Fontaniere S , TostJ , WierinckxAet al. Gene expression profiling in insulinomas of Men1 beta-cell mutant mice reveals early genetic and epigenetic events involved in pancreatic beta-cell tumorigenesis . Endocr. Relat. Cancer13 ( 4 ), 1223 – 1236 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Dejeux E , OlasoR , DoussetBet al. Hypermethylation of the IGF2 differentially methylated region 2 is a specific event in insulinomas leading to loss-of-imprinting and overexpression . Endocr. Relat. Cancer16 ( 3 ), 939 – 952 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Bibikova M , LinZ , ZhouLet al. High-throughput DNA methylation profiling using universal bead arrays . Genome Res.16 ( 3 ), 383 – 393 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Kloppel G , PerrenA , HeitzPU . The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification . Ann. NY Acad. Sci.1014 , 13 – 27 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Kloppel G . Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms . Endocr. Relat. Cancer18 ( Suppl. 1 ), S1 – S16 ( 2011 ).
   PubMedGoogle Scholar
• Bibikova M , FanJB . GoldenGate assay for DNA methylation profiling . Methods Mol. Biol.507 , 149 – 163 ( 2009 ).
   PubMedGoogle Scholar
• Suzuki R , ShimodairaH . Pvclust: an R package for assessing the uncertainty in hierarchical clustering . Bioinformatics22 ( 12 ), 1540 – 1542 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Tost J , GutIG . DNA methylation analysis by pyrosequencing . Nat. Protoc.2 ( 9 ), 2265 – 2275 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Rodriguez-Rodero S , Delgado-AlvarezE , FernandezAF , Fernandez-MoreraJL , Menendez-TorreE , FragaMF . Epigenetic alterations in endocrine-related cancer . Endocr. Relat. Cancer21 ( 4 ), R319 – R330 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• UniProt . www.uniprot.org .
   Google Scholar
• Bibikova M , BarnesB , TsanCet al. High density DNA methylation array with single CpG site resolution . Genomics98 ( 4 ), 288 – 295 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Lister R , PelizzolaM , DowenRHet al. Human DNA methylomes at base resolution show widespread epigenomic differences . Nature462 ( 7271 ), 315 – 322 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Rosty C , UekiT , ArganiPet al. Overexpression of S100A4 in pancreatic ductal adenocarcinomas is associated with poor differentiation and DNA hypomethylation . Am. J. Pathol.160 ( 1 ), 45 – 50 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Duerr EM , ChungDC . Molecular genetics of neuroendocrine tumors . Best Pract. Res. Clin. Endocrinol. Metab.21 ( 1 ), 1 – 14 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Corbo V , DalaiI , ScardoniMet al. MEN1 in pancreatic endocrine tumors: analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of cases . Endocr. Relat. Cancer17 ( 3 ), 771 – 783 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Paredes J , AlbergariaA , OliveiraJT , JeronimoC , MilaneziF , SchmittFC . P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation . Clin. Cancer Res.11 ( 16 ), 5869 – 5877 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Ehrlich M . DNA hypomethylation in cancer cells . Epigenomics1 ( 2 ), 239 – 259 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Jordan PH Jr . A personal experience with pancreatic and duodenal neuroendocrine tumors . J. Am. Coll. Surg.189 ( 5 ), 470 – 482 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Fendrich V , LangerP , WaldmannJ , BartschDK , RothmundM . Management of sporadic and multiple endocrine neoplasia type 1 gastrinomas . Br. J. Surg.94 ( 11 ), 1331 – 1341 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Fendrich V , RamerthR , WaldmannJet al. Sonic hedgehog and pancreatic-duodenal homeobox 1 expression distinguish between duodenal and pancreatic gastrinomas . Endocr. Relat. Cancer16 ( 2 ), 613 – 622 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Wolff EM , ChiharaY , PanFet al. Unique DNA methylation patterns distinguish noninvasive and invasive urothelial cancers and establish an epigenetic field defect in premalignant tissue . Cancer Res.70 ( 20 ), 8169 – 8178 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Esteller M . CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future . Oncogene21 ( 35 ), 5427 – 5440 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Banck MS , KanwarR , KulkarniAAet al. The genomic landscape of small intestine neuroendocrine tumors . J. Clin. Invest.123 ( 6 ), 2502 – 2508 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Lindberg D , AkerstromG , WestinG . Mutational analysis of p27 (CDKN1B) and p18 (CDKN2C) in sporadic pancreatic endocrine tumors argues against tumor-suppressor function . Neoplasia9 ( 7 ), 533 – 535 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Lindberg D , AkerstromG , WestinG . Evaluation of CDKN2C/p18, CDKN1B/p27 and CDKN2B/p15 mRNA expression, and CpG methylation status in sporadic and MEN1-associated pancreatic endocrine tumours . Clin. Endocrinol. (Oxf.)68 ( 2 ), 271 – 277 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Milne TA , HughesCM , LloydRet al. Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors . Proc. Natl Acad. Sci. USA102 ( 3 ), 749 – 754 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Fontaniere S , CasseH , BertolinoP , ZhangCX . Analysis of p27(Kip1) expression in insulinomas developed in pancreatic beta-cell specific Men1 mutant mice . Fam. Cancer5 ( 1 ), 49 – 54 ( 2006 ).
   PubMed Web of Science ®Google Scholar